Dravet Syndrome Market Insight and Market Forecast

According to the Dravet Syndrome Foundation, Dravet syndrome (DS) is a rare, catastrophic, lifelong form of epilepsy that begins in the first year of life with frequent and/or prolonged seizures.

The Signs and Symptoms of the disease involve seizures, ataxia (balance problems), motor impairment, cognitive impairment, behavioral problems, infections, bone problems, and heart rhythm irregularities.

As per DelveInsight’s estimates, the United States accounted for the maximum number of DS patients with 20,731 cases in 2017 followed by Germany with 2,896 cases.
DelveInsight estimates suggest that Missense mutation was found to have the highest number of incident cases among the DS patient population in the US.
According to the paper titled as “Mortality in Dravet syndrome: A review” written by Shmuely S et al. 2016 nearly ~73% of the patients die before the age of 10 years. Sudden unexpected death) in epilepsy (SUDEP was the leading cause of death (~49%) followed by status epilepticus (~32%).

For more information visit:
https://www.delveinsight.com/report-store/dravet-syndrome-market